Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity

BACKGROUND: Effective antiviral treatment (direct-acting antiviral agents (DAAs)), the requirement for a fibrosis score to support DDA reimbursement and a screening strategy, such as the USA baby boomer campaign, should lead to an increased awareness of liver disease severity. OBJECTIVE: To compare...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMJ Open
Autori principali: Poynard, Thierry, Deckmyn, Olivier, Munteanu, Mona, Ngo, Yen, Drane, Fabienne, Castille, Jean Marie, Housset, Chantal, Ratziu, Vlad
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2015
Soggetti:
Gastroenterology and Hepatology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4691773/
https://ncbi.nlm.nih.gov/pubmed/26700292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2015-010017
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi